Lapatinib
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3688 publications
Title Not Found
Journal: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke
Published: September 08, 2026
Integrated multi-omics, machine learning, network toxicology, and molecular docking reveal potential mechanisms underlying methyl 4-hydroxybenzoate-associated breast cancer.
Journal: Molecular diversity
Published: July 16, 2026
Editor's Note: Lapatinib, a Dual EGFR and HER2 Kinase Inhibitor, Selectively Inhibits HER2-Amplified Human Gastric Cancer Cells and is Synergistic with Trastuzumab In vitro and In vivo.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 13, 2026
A CFH- and SPINT2-based prognostic signature for cholangiocarcinoma.
Journal: Journal of gastrointestinal oncology
Published: July 09, 2026
Drug-induced paronychia: a disproportionality and time-to-onset pharmacovigilance study using FAERS and JADER.
Journal: Cutaneous and ocular toxicology
Published: July 07, 2026
Corrigendum to "PI3K PROTAC overcomes the lapatinib resistance in PIK3CA-mutant HER2 positive breast cancer" [Cancer Lett. 598 (2024) 217112].
Journal: Cancer letters
Published: June 30, 2026
Anti-RSV drug screening and inhibition of RSV infection by lapatinib through the IL-17 pathway.
Journal: Antimicrobial agents and chemotherapy
Published: June 30, 2026
Identification of Hub Genes, Single-Nucleotide Polymorphisms, and Potential Drug Targets In Breast Cancer Using Transcriptomic Analysis.
Journal: Journal of visualized experiments : JoVE
Published: June 29, 2026
Tannic acid protects against lapatinib-induced hepatotoxicity by inhibiting cathepsin activity and repairing lysosomal membrane permeabilization.
Journal: Toxicology and applied pharmacology
Published: June 23, 2026
Correction to "[NSUN2 promotes colorectal cancer progression and increases lapatinib sensitivity by enhancing CUL4B/ErbB-STAT3 signalling in a non-m5C manner]".
Journal: Clinical and translational medicine
Published: June 16, 2026
EGFR INHIBITION PROMOTES ENTEROENDOCRINE CELL DIFFERENTIATION CONTRIBUTING TO TREATMENT-ASSOCIATED DIARRHEA.
Journal: bioRxiv : the preprint server for biology
Published: June 12, 2026
Design, synthesis, and biological evaluation of quinolin-2-one/thiazole hybrids as multi-targeted antiproliferative agents inducing caspase-dependent apoptosis.
Journal: Scientific reports
Published: June 06, 2026
Last Updated: 09/26/2026